Skip to main navigation Skip to search Skip to main content

Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review

  • Sérgio Barra
  • , Rui Providência
  • , Kumar Narayanan
  • , Serge Boveda
  • , Rudolf Duehmke
  • , Rodrigue Garcia
  • , Francisco Leyva
  • , Véronique Roger
  • , Xavier Jouven
  • , Sharad Agarwal
  • , Wayne C Levy
  • , Eloi Marijon
  • Cardiology Department, Royal Papworth Hospital NHS Foundation Trust, Papworth Rd, Cambridge CB2 0AY, UK
  • Cardiology Department, Barts Heart Centre, Barts Health NHS Trust, W Smithfield, London EC1A 7BE, UK
  • Paris Cardiovascular Research Center (Inserm U970), Cardiovascular Epidemiology Unit, 56 Rue Leblanc, 75015 Paris, France
  • Cardiology Department, Clinique Pasteur, 45 Avenue de Lombez - BP 27617 - 31076 TOULOUSE, 31300 Toulouse, France
  • Cardiology Department, James Paget University Hospital, Lowestoft Road Gorleston-on-Sea, Great Yarmouth NR31 6LA, UK
  • Cardiology Department, Poitiers University Hospital, 2 Rue de la Milétrie, 86021 Poitiers, France
  • Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, 200 1st St SW, Rochester, MN 55905, USA
  • Paris Descartes University, 12 Rue de l'École de Médecine, 75006 Paris, France
  • Division of Cardiology, University of Washington, Seattle, WA, USA

Research output: Contribution to journalArticlepeer-review

43   Link opens in a new tab Citations (SciVal)

Abstract

Aims:
While data from randomized trials suggest a declining incidence of sudden cardiac death (SCD) among heart failure patients, the extent to which such a trend is present among patients with cardiac resynchronization therapy (CRT) has not been evaluated. We therefore assessed changes in SCD incidence, and associated factors, in CRT recipients over the last 20 years.

Methods and results:
Literature search from inception to 30 April 2018 for observational and randomized studies involving CRT patients, with or without defibrillator, providing specific cause-of-death data. Sudden cardiac death was the primary endpoint. For each study, rate of SCD per 1000 patient-years of follow-up was calculated. Trend line graphs were subsequently constructed to assess change in SCD rates over time, which were further analysed by device type, patient characteristics, and medical therapy. Fifty-three studies, comprising 22 351 patients with 60 879 patient-years of follow-up and a total of 585 SCD, were included. There was a gradual decrease in SCD rates since the early 2000s in both randomized and observational studies, with rates falling more than four-fold. The rate of decline in SCD was steeper than that of all-cause mortality, and accordingly, the proportion of deaths which were due to SCD declined over the years. The magnitude of absolute decline in SCD was more prominent among CRT-pacemaker (CRT-P) patients compared to those receiving CRT-defibrillator (CRT-D), with the difference in SCD rates between CRT-P and CRT-D decreasing considerably over time. There was a progressive increase in age, use of beta-blockers, and left ventricular ejection fraction, and conversely, a decrease in QRS duration and antiarrhythmic drug use.

Conclusion:
Sudden cardiac death rates have progressively declined in the CRT heart failure population over time, with the difference between CRT-D vs. CRT-P recipients narrowing considerably.
Original languageEnglish
Pages (from-to)1976–1986
Number of pages11
JournalEuropean Heart Journal
Volume41
Issue number21
Early online date21 Nov 2019
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • Sudden death
  • Cardiac resynchronization
  • Implantable cardioverter-defibrillator
  • Biventricular pacemaker
  • Heart failure

Fingerprint

Dive into the research topics of 'Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review'. Together they form a unique fingerprint.

Cite this